Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 06 04; 382(23):2187-2196.
View in:
PubMed
subject areas
Adenocarcinoma
Adenocarcinoma
Administration, Oral
Administration, Oral
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Hormonal
Cardiovascular Diseases
Cardiovascular Diseases
Gonadotropin-Releasing Hormone
Gonadotropin-Releasing Hormone
Humans
Humans
Injections, Subcutaneous
Injections, Subcutaneous
Leuprolide
Leuprolide
Male
Male
Middle Aged
Middle Aged
Phenylurea Compounds
Phenylurea Compounds
Prostatic Neoplasms
Prostatic Neoplasms
Pyrimidinones
Pyrimidinones
Testosterone
Testosterone
authors with profiles
Michael S Cookson